Optimizing Frontline Hodgkin Lymphoma Treatment

Dr. Stephen Ansell, an expert from the Mayo Clinic , shares why he feels it is an “optimistic time” for Hodgkin lymphoma patients. Dr. Ansell explains what recent studies suggest about modifying and optimizing therapies in the frontline setting. He discusses new and developing treatments that are helping to build on existing regimens and combinations, while minimizing toxicity and increasing efficacy.

Get email alerts | http://www.patientpower.info/alerts

Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower